Apolipoprotein A1 (APOA1): APOA1 in plasma was identified as a potential biomarker for acute cellular rejection in kidney transplant recipients utilizing surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Here, APOA1 is linked to medical procedure.